N

NRX Pharmaceuticals
D

NRXP

3.77000
USD
-0.13
(-3.21%)
مغلق
حجم التداول
39,077
الربح لكل سهم
-0
العائد الربحي
-
P/E
-4
حجم السوق
161,357,583
أصول ذات صلة المقالات
المزيد

العنوان: NRX Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.